Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 38.05
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
Easywell Biomedicals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 281.06 | 325.67 | 262.91 | 159.03 | 153.03 | Upgrade
|
| Short-Term Investments | 130.2 | 120.27 | 85.12 | 180.51 | 271.24 | Upgrade
|
| Trading Asset Securities | 40.43 | 20.16 | - | - | 15.01 | Upgrade
|
| Cash & Short-Term Investments | 451.69 | 466.1 | 348.03 | 339.54 | 439.28 | Upgrade
|
| Cash Growth | -3.09% | 33.92% | 2.50% | -22.71% | 90.50% | Upgrade
|
| Accounts Receivable | 39.13 | 42.45 | 66.93 | 20.48 | 30.58 | Upgrade
|
| Other Receivables | 26.88 | 15.51 | 1.38 | 3.52 | 3.23 | Upgrade
|
| Receivables | 66.01 | 57.96 | 68.31 | 23.99 | 33.82 | Upgrade
|
| Inventory | 158.54 | 259.26 | 42.17 | 26.83 | 20.55 | Upgrade
|
| Prepaid Expenses | 23.78 | 34.88 | 49.12 | 22.09 | 16.45 | Upgrade
|
| Total Current Assets | 700.01 | 818.2 | 507.64 | 412.44 | 510.09 | Upgrade
|
| Property, Plant & Equipment | 487.21 | 545.49 | 542.2 | 572.71 | 555.54 | Upgrade
|
| Long-Term Investments | 0.06 | 0.06 | 0.06 | 0.06 | - | Upgrade
|
| Other Intangible Assets | 101.24 | 136.52 | 156.1 | 168.44 | 179.84 | Upgrade
|
| Other Long-Term Assets | 3.78 | 5.04 | 7.8 | 19.5 | 18.44 | Upgrade
|
| Total Assets | 1,292 | 1,505 | 1,214 | 1,173 | 1,264 | Upgrade
|
| Accounts Payable | 8.22 | 45.63 | 9.42 | 2.36 | 0.47 | Upgrade
|
| Short-Term Debt | 89.92 | 201.09 | 43.27 | - | - | Upgrade
|
| Current Portion of Leases | 24.49 | 20.73 | 12.63 | 11.47 | 9.86 | Upgrade
|
| Current Unearned Revenue | 68.5 | 33.74 | 39.8 | 34.19 | 11.75 | Upgrade
|
| Other Current Liabilities | 87.11 | 122.51 | 22.45 | 16.1 | 14.11 | Upgrade
|
| Total Current Liabilities | 278.23 | 423.71 | 127.57 | 64.11 | 36.18 | Upgrade
|
| Long-Term Leases | 311.51 | 342.46 | 330.45 | 338.48 | 315.64 | Upgrade
|
| Other Long-Term Liabilities | - | - | 131.97 | - | - | Upgrade
|
| Total Liabilities | 589.74 | 766.17 | 589.99 | 402.6 | 351.82 | Upgrade
|
| Common Stock | 1,247 | 1,218 | 1,159 | 1,144 | 1,634 | Upgrade
|
| Additional Paid-In Capital | 188.97 | 132.98 | 35.4 | 1.11 | 90.87 | Upgrade
|
| Retained Earnings | -760.93 | -654.35 | -570.16 | -422.31 | -841.21 | Upgrade
|
| Comprehensive Income & Other | 15.74 | 22.07 | -11.09 | 16.01 | -9.8 | Upgrade
|
| Total Common Equity | 690.67 | 718.61 | 612.81 | 738.46 | 873.66 | Upgrade
|
| Minority Interest | 11.88 | 20.53 | 10.98 | 32.1 | 38.44 | Upgrade
|
| Shareholders' Equity | 702.56 | 739.14 | 623.8 | 770.56 | 912.09 | Upgrade
|
| Total Liabilities & Equity | 1,292 | 1,505 | 1,214 | 1,173 | 1,264 | Upgrade
|
| Total Debt | 425.91 | 564.28 | 386.34 | 349.96 | 325.5 | Upgrade
|
| Net Cash (Debt) | 25.78 | -98.19 | -38.31 | -10.42 | 113.78 | Upgrade
|
| Net Cash Per Share | 0.21 | -0.82 | -0.33 | -0.09 | 1.07 | Upgrade
|
| Filing Date Shares Outstanding | 124.69 | 121.79 | 115.87 | 114.37 | 114.37 | Upgrade
|
| Total Common Shares Outstanding | 124.69 | 121.79 | 115.87 | 114.37 | 114.37 | Upgrade
|
| Working Capital | 421.78 | 394.49 | 380.07 | 348.33 | 473.91 | Upgrade
|
| Book Value Per Share | 5.54 | 5.90 | 5.29 | 6.46 | 7.64 | Upgrade
|
| Tangible Book Value | 589.44 | 582.09 | 456.72 | 570.02 | 693.81 | Upgrade
|
| Tangible Book Value Per Share | 4.73 | 4.78 | 3.94 | 4.98 | 6.07 | Upgrade
|
| Machinery | 529.8 | 535.61 | 487.94 | 481.86 | 462.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.